Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) Other Non Operating Income (2021 - 2025)

Biote has reported Other Non Operating Income over the past 5 years, most recently at $2.9 million for Q3 2025.

  • Quarterly results put Other Non Operating Income at $2.9 million for Q3 2025, down 59.52% from a year ago — trailing twelve months through Sep 2025 was -$18.5 million (up 33.34% YoY), and the annual figure for FY2024 was -$19.6 million, down 118.08%.
  • Other Non Operating Income for Q3 2025 was $2.9 million at Biote, up from -$1.8 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for BTMD hit a ceiling of $17.4 million in Q3 2023 and a floor of -$25.4 million in Q1 2023.
  • Median Other Non Operating Income over the past 5 years was -$11000.0 (2023), compared with a mean of -$3.0 million.
  • Biggest five-year swings in Other Non Operating Income: soared 173150.0% in 2022 and later tumbled 348625.0% in 2024.
  • Biote's Other Non Operating Income stood at $4000.0 in 2021, then soared by 173150.0% to $6.9 million in 2022, then plummeted by 229.52% to -$9.0 million in 2023, then plummeted by 118.37% to -$19.6 million in 2024, then surged by 114.9% to $2.9 million in 2025.
  • The last three reported values for Other Non Operating Income were $2.9 million (Q3 2025), -$1.8 million (Q2 2025), and -$18000.0 (Q1 2025) per Business Quant data.